Plant ID: NPO3102
Plant Latin Name: Arachniodes exilis
Taxonomy Genus: Arachniodes
Taxonomy Family: Dryopteridaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
TSHR; | |
CDC25B; | |
PPARD; PPARA; | |
TLR2; | |
STAT3; TP53; | |
KLF5; FABP3; FABP2; FABP4; GMNN; LMNA; FABP5; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Phosphatase | CDC25B | Dual specificity phosphatase Cdc25B | P30305 | CHEMBL4804 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Transcription Factor | STAT3 | Signal transducer and activator of transcription 3 | P40763 | CHEMBL4026 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | KLF5 | Kruppel-like factor 5 | Q13887 | CHEMBL1293249 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | GMNN | Geminin | O75496 | CHEMBL1293278 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 7.306E-09 | 3.182E-05 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 1.042E-08 | 3.242E-05 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0032502; developmental process | GO:0048856; anatomical structure development | 1.383E-08 | 3.346E-05 | CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP5, KLF5, LMNA, PPARA, PPARD, SMN1, SMN2, STAT3, TLR2, TP53, TSHR |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 1.134E-07 | 1.319E-04 | CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.212E-07 | 1.319E-04 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.248E-06 | 9.367E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 1.659E-06 | 1.095E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009299; mRNA transcription | 2.152E-06 | 1.266E-03 | PPARD, STAT3, TP53 |
BP | GO:0008283; cell proliferation | GO:0008285; negative regulation of cell proliferation | 4.244E-06 | 2.100E-03 | CYP1B1, FABP3, LMNA, PPARD, STAT3, TLR2, TP53 |
BP | GO:0050896; response to stimulus | GO:0014070; response to organic cyclic compound | 5.247E-06 | 2.380E-03 | CYP1A1, CYP1A2, CYP1B1, KLF5, STAT3, TLR2, TP53 |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 6.104E-06 | 2.712E-03 | CYP1A1, CYP1A2 |
MF | GO:0005488; binding | GO:0020037; heme binding | 8.209E-06 | 3.438E-03 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0009987; cellular process | GO:0071310; cellular response to organic substance | 1.572E-05 | 6.067E-03 | CYP1A1, CYP1B1, FABP4, KLF5, PPARD, STAT3, TP53, TSHR |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 1.697E-05 | 6.241E-03 | PPARA, PPARD, STAT3 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 1.981E-05 | 6.847E-03 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0097371; MDM2/MDM4 family protein binding | 2.132E-05 | 7.143E-03 | PPARA, TP53 |
BP | GO:0008152; metabolic process | GO:0050665; hydrogen peroxide biosynthetic process | 2.841E-05 | 9.234E-03 | CYP1A1, CYP1A2 |
MF | GO:0005488; binding | GO:0070491; repressing transcription factor binding | 3.128E-05 | 9.731E-03 | GMNN, PPARA, STAT3 |
CC | GO:0043226; organelle | GO:0005654; nucleoplasm | 5.657E-05 | 1.579E-02 | CDC25B, FABP5, GMNN, KLF5, LMNA, PPARA, PPARD, SMN1, SMN2, STAT3, TP53 |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 6.681E-05 | 1.753E-02 | SMN1, SMN2 |
CC | GO:0032991; macromolecular complex | GO:0032797; SMN complex | 7.890E-05 | 1.997E-02 | SMN1, SMN2 |
CC | GO:0044464; cell part | GO:0034719; SMN-Sm protein complex | 1.543E-04 | 3.200E-02 | SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 5.037E-11 | 4.080E-09 | FABP2, FABP3, FABP4, FABP5, PPARA, PPARD |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 2.979E-07 | 1.207E-05 | CYP1A2, CYP1A1, CYP1B1, CYP19A1 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 8.252E-06 | 2.228E-04 | CYP1A2, CYP1A1, CYP1B1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 1.627E-05 | 3.294E-04 | CYP1A1, CYP1B1, CYP19A1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.086E-05 | 8.240E-04 | CYP1A2, CYP1A1, CYP1B1 |
09160 Human Diseases | 09161 Cancers | hsa05206 | MicroRNAs in cancer | 1.914E-04 | 2.214E-03 | STAT3, CYP1B1, TP53, CDC25B |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 7.201E-05 | 9.721E-04 | CYP1A2, CYP1A1, CYP1B1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05160 | Hepatitis C | 3.017E-04 | 2.899E-03 | STAT3, PPARA, TP53 |
09160 Human Diseases | 09167 Infectious diseases | hsa05161 | Hepatitis B | 3.966E-04 | 3.213E-03 | STAT3, TP53, TLR2 |
09160 Human Diseases | 09167 Infectious diseases | hsa05162 | Measles | 3.221E-04 | 2.899E-03 | STAT3, TP53, TLR2 |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 1.034E-03 | 7.614E-03 | STAT3, TP53, TLR2 |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 1.467E-03 | 9.141E-03 | STAT3, PPARD |
09150 Organismal Systems | 09152 Endocrine system | hsa04923 | Regulation of lipolysis in adipocytes | 1.416E-03 | 9.141E-03 | FABP4, TSHR |
09160 Human Diseases | 09162 Immune diseases | hsa05321 | Inflammatory bowel disease (IBD) | 1.903E-03 | 9.928E-03 | STAT3, TLR2 |
09160 Human Diseases | 09161 Cancers | hsa05212 | Pancreatic cancer | 1.961E-03 | 9.928E-03 | STAT3, TP53 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.903E-03 | 9.928E-03 | CYP1A2, CYP1A1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | TP53; |
N00-N99: Diseases of the genitourinary system | Endometriosis | N80 | CYP19A1; |
C00-D49: Neoplasms | Breast cancer | C50 | CYP19A1; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Toxicity | T36-T50, T51-T65 | TP53; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TP53; |
H60-H95: Diseases of the ear and mastoid process | Hearing disorder | H90.5 | TP53; |
C00-D49: Neoplasms | Advanced breast cancer | C50 | CYP19A1; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TP53; |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | TP53; |
N00-N99: Diseases of the genitourinary system | Prostate disease | N42.9 | CYP19A1; |
I00-I99: Diseases of the circulatory system | Renal artery disease | I70.1 | TP53; |
C00-D49: Neoplasms | Bladder cancer | C67 | CYP19A1; |
C00-D49: Neoplasms | Cancer | C00-C96 | TP53; |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | TP53; |
G00-G99: Diseases of the nervous system G00-G99 | Spinal muscular atrophy | G00-G99 | SMN1;SMN2; |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1; |